The research company Peptonic Medical's rights issue of units was subscribed to approximately 52.5 percent. In addition, guarantee commitments corresponding to approximately 14.5 percent are utilized. In total, the company will receive approximately SEK 10 million before issue costs and set-offs. A total of just over 49 million units were subscribed, consisting of shares and free-of-charge warrants of series TO6.Upon full exercise of warrants of series TO6 issued in the rights issue, an additional approximately SEK 10 million may be raised.The issue is part of the company's reconstruction plan and entails a dilution of approximately 54.7 percent for shareholders who did not participate.